Anti-HLA DSA and Beyond: deciphering the immunological mechanisms driving chronic rejection

About this Special Issue

  1. Manuscript Submission Deadline 30 May 2025

Background

Despite the progress achieved over the last two decades in the field of therapeutic immunosuppression, immune-mediated destruction of allograft (aka chronic rejection) remains among the first causes of late failure. A better understanding of the mechanisms involved first in allorecognition and then in generating graft damages and allograft fibrosis, appears as a mandatory step to design future innovative therapeutic strategies with the potential to improve long-term outcomes.

This Special Issue of Transplant International gathers the best international experts to propose a synthesis of the latest advances in transplant immunology in the field of chronic rejection immunopathology.


Important
As a Gold open-access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.

Please see the following pages for:
Publishing Fees
Author Guidelines

Special Issue Research topic image

Article types and fees

This Special Issue accepts the following article types, unless otherwise specified in the Special Issue description:

  • Brief Research Report
  • Consensus Report
  • Editorial
  • Executive Summary
  • Forum
  • Guidelines
  • In Memoriam
  • Letter to the Editor
  • Meeting Report

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: allograft, immunosuppression, allorecognition, allograft fibrosis

Issue editors

Manuscripts can be submitted to this Special Issue via the main journal or any other participating journal.